跳至主要内容
临床试验/NL-OMON39347
NL-OMON39347已完成不适用

The role of miRNAs in the biology of Barrett*s esophagus - The role of miRNAs in the biology of Barrett*s esophagus

niversitair Medisch Centrum Groningen0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • For the group with advanced esophageal adenocarcinoma > stage 1A :
  • Patients older than 18 years with esophageal adenocarinoma with stage 1B or higher that are scheduled for esophagogastroduodenoscopy.
  • For the high-grade dysplasia or esophageal adenocarcinoma group:
  • Patients older than 18 years with Barrett's esophagus and esophageal adenocarinoma until stage 1A (established on the basis of a histological biopsy) that are scheduled for esophagogastroduodenoscopy.
  • For the non-dysplastic Barrett's esophagus group:
  • Patients older than 18 years with long-standing non-dysplastic Barrett's esophagus that are under surveillance and have not shown any signs of malignant progression.
  • For the gastro-esophgeal reflux disease group patients:
  • Patients older than 18 years without Barrett's esophagus but with reflux disease, confirmed by an esophagogastroduodenoscopy
  • For the control group patients:
  • Patients older than 18 years without Barrett's esophagus or reflux disease, confirmed by an esophagogastroduodenoscopy

排除标准

  • Patients younger than 18 years
  • Patients unfit to undergo esophagogastroduodenoscopy.
  • Patients in whom no samples of either squamous epithelium, Barrett's esophagus or esophageal adenocarcinoma epithelium could be obtained for different reasons, as judged by the endoscopist
  • For the gastro-esophgeal reflux disease group patients: the presence of Barrett's esophagus

研究者

相似试验